Capvizr
THE DEAL, AT A GLANCE

Craif

From the announcement
01What happenedCraif raised $33M Series DFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
02Why it mattersCraif's Series D financing supports a transition from Japan-based urine analysis bio-AI commercialization toward U.S.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement ↗
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗

Craif · Financing Record

Explore source-linked visual explanations for Craif. Unsupported claims are withheld while source review continues.

Record 10805 · Recorded date: Needs review

What it does

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 10805 →

Explore company records →
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free · Unsubscribe anytime